RayzeBio

rayzebio.com

Rayze Bio is a vertically integrated radiopharmaceutical therapeutics company dedicated to improving cancer patient survival through the development of targeted innovative drugs that utilize radioisotopes. The company has established a diverse portfolio of drug candidates, advancing them from discovery to late-stage clinical programs, and employs a systematic, data-driven approach to drug discovery and development. With over 500 in-vivo experiments conducted, Rayze Bio is positioned as a leader in the radiopharmaceutical market, focusing on delivering therapies directly to solid tumors to selectively kill cancer cells.